secwatch.observer — SEC 8-K summary
======================================

Issuer:     Boundless Bio, Inc. (BOLD)
CIK:        0001782303
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0000950170-25-089002
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Boundless Bio annual meeting elects two directors, ratifies KPMG as auditor
---------------------------------------------------------------------------

- Christine Brennan, Ph.D. elected as Class I director with 9,252,440 votes for and 5,046,258 withheld; 3,540,518 broker non-votes.
- Nancy Whiting, Pharm.D. elected as Class I director with 9,758,214 votes for and 4,540,484 withheld; 3,540,518 broker non-votes.
- Ratification of KPMG LLP as independent auditor for FY2025: 17,791,309 for, 47,807 against, 100 abstain.
- Meeting held on June 23, 2025; both proposals were standard agenda items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782303/000095017025089002/0000950170-25-089002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782303/000095017025089002/bold-20250623.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-089002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer